000 01365 a2200349 4500
005 20250517053528.0
264 0 _c20160104
008 201601s 0 0 eng d
022 _a1477-9129
024 7 _a10.1242/dev.126482
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThies, R Scott
245 0 0 _aThe advancement of human pluripotent stem cell-derived therapies into the clinic.
_h[electronic resource]
260 _bDevelopment (Cambridge, England)
_cSep 2015
300 _a3077-84 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aCell Differentiation
_xphysiology
650 0 4 _aCell- and Tissue-Based Therapy
_xmethods
650 0 4 _aDiabetes Mellitus, Type 1
_xtherapy
650 0 4 _aGovernment Regulation
650 0 4 _aHeart Failure
650 0 4 _aHumans
650 0 4 _aParkinson Disease
_xtherapy
650 0 4 _aPluripotent Stem Cells
_xtransplantation
650 0 4 _aRegenerative Medicine
_xmethods
650 0 4 _aRetinal Degeneration
_xtherapy
650 0 4 _aSignal Transduction
_xphysiology
650 0 4 _aSpinal Cord Injuries
_xtherapy
700 1 _aMurry, Charles E
773 0 _tDevelopment (Cambridge, England)
_gvol. 142
_gno. 18
_gp. 3077-84
856 4 0 _uhttps://doi.org/10.1242/dev.126482
_zAvailable from publisher's website
999 _c25284991
_d25284991